Clinical Downloads – RedDress

Now eligible for reimbursement from Medicare and Medicare Advantage! Learn More

Published Papers

Filter by:

Efficacy and safety of autologous whole blood clot in diabetic foot ulcers: a randomised controlled trial

Safety And Efficacy of An Autologous Blood Clot Product in The Management of Texas 1A Or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study

Efficacy And Safety of A Novel Autologous Wound Matrix in The Management Of Complicated, Chronic Wounds: A Pilot Study

Real-World Outcomes of Autologous Whole Blood Clot Therapy for Venous Leg Ulcers

Innovative Treatment Utilizing an Autologous Blood Clot for Diabetic Foot Ulcers

Utilization of a topical autologous blood clot for treatment of pressure ulcers

An observational pilot study to collect safety and efficacy data on wound care using whole blood clot technology on hard-to-heal wounds

Comparative Effectiveness of Autologous Blood Clot Therapy (ActiGraft), Autologous Micrograft Therapy (Rigenera), and Advanced Wound Dressings for Refractory Chronic Lower Limb Ulcers: A Real-World Evidence Study

Use of Autologous Whole Blood Clot for Hard-To-Heal Diabetic Foot Ulcers

Use of autologous whole blood clot in the treatment of complex surgical wounds: a case series

Utilization of ActiGraft, An Autologous Whole Blood Clot, for Treatment of Complex Wounds Linked to Comorbidities

The Use of Active Coagulation Whole Blood—An Innovative Treatment Strategy for Hard-To-Heal Wounds

ActiGraft Treatment in Complex Wounds with Exposed Structure

Autologous Whole-Blood Clot Therapy for Refractory Diabetic Foot and Ankle Wounds: Preliminary Clinical Findings

A Retrospective Case Series from South Africa: Management of Diabetic Foot Ulcers with ActiGraft, an Autologous Whole-Blood Clot Therapy

Chronic Venous Ulcer Pain Reduction And Full Recovery By An Autologous Blood Clot: A Case Study

Utilization of ActiGraft, an Autologous (Blood Clot) Graft in the Reconstruction of Soft Tissue Deficit from Hand Trauma

The Use of ActiGraft, an Autologous Skin Graft, in the Treatment of Complex Diabetes Foot Ulcer

Use of autologous whole blood clot for hard-to-heal diabetic foot ulcers: a case series

A Prospective, Single-Arm Study to Evaluate the Safety and Efficacy of RD2-Ver.02, an Autologous Blood Clot, in the Treatment of Anal Fistula

Efficacy and Safety of RD2 Ver.02, A Whole Blood Clot Therapy, Coupled With A Minimally Invasive Procedure in Pilonidal Sinus: A Phase II Study

Autologous Whole Blood Clot Formation with ActiGraft in Patients Receiving Oral Anticoagulant Therapy: An Ex Vivo Feasibility Study

Proposed Mechanism of Action of Topically Applied Autologous Blood Clot Tissue

Uso de una matriz autóloga en el tratamiento de úlceras de pie diabético, con espectroscopia de infrarrojo cercano y medidor de pH dérmico

Nerve Reconstruction Using ActiGraft Blood Clot in Rabbit Acute Peripheral Injury Model: Preliminary Study

The safety of an autologous whole blood clot product applied to full thickness dermal wounds in a porcine model for up to 18 days

Breaking the Cycle of Hard-To-Heal Wounds: The Role of Autologous Whole Blood Clot Therapy

Actigraft™ Topically Applied Blood Clot Therapy

Topical Autologous Blood Clot Therapy: Consensus Panel Recommendations to Guide Use in the Treatment of Complex Wound Types

Topical Autologous Blood Clot Therapy: An Introduction and Development of Consensus Panel to Guide Use in the Treatment of Complex Wound Types

Autologous whole blood clot and negative-pressure wound therapy in South Africa: A comparison of the cost and social considerations

A Comparative Analysis of the Cost Effectiveness of Five Advanced Skin Substitutes in the Treatment of Foot Ulcers in Patients with Diabetes

Ready to reimagine your approach to wound healing?

ActiGraft^Pro empowers you to choose with confidence.

Get Started